01 1Srini Pharmaceuticals
01 1LABETALOL HYDROCHLORIDE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-07-01
Pay. Date : 2021-04-12
DMF Number : 34073
Submission : 2019-08-29
Status : Active
Type : II
20
Srini Pharmaceuticals Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is LABETALOL HYDROCHLORIDE USP, with a corresponding US DMF Number 34073.
Remarkably, this DMF maintains an Active status since its submission on August 29, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 01, 2021, and payment made on April 12, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
